AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for Relapsed/Refractory Multiple Myeloma
Sites in Stony Brook, New York +32 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05850234·Phase 1, Phase 2·Recruiting·Listed May 2023
Paid Clinical Trials in Stony Brook, NY
As of August 2026, 173 paid clinical trials are recruiting in Stony Brook, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
168 clinical trials
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for Acute Coronary Syndrome
Sites in Stony Brook, The Bronx +146 more locations
Sponsor: DalCor Pharmaceuticals
Sex: All·Age: 45+
Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023
Product Surveillance Registry
for Cardiac Rhythm Disorders
Sites in Stony Brook, Port Jefferson +127 more locations
Sponsor: Medtronic
Sex: All·Age: All ages
Code: NCT01524276·Recruiting·Listed Feb 2012
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
for Lupus Nephritis
Sites in Stony Brook, New York +14 more locations
Sponsor: Nkarta, Inc.
Sex: All·Age: 18 - 75
Code: NCT06557265·Phase 1, Phase 2·Recruiting·Listed Aug 2024
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
for Multiple Myeloma
Drug: Belantamab mafodotin
Sites in Stony Brook, New York +28 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024